Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 6:23 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 105 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Post Myocardial Infarction Clear all

Conditions: Stress Disorders, Post-Traumatic
Interventions: Cognitive behavioral therapy (CBT), Educational session and treatment as usual; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 2
States / cities: New York, New York • Queens, New York

Conditions: Myocardial Infarction, Stable Angina, Coronary Artery Disease
Interventions: Early appointment (within 10 days), Routine referral (at 5 weeks); Behavioral · Other
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Post Myocardial Infarction
Interventions: Cardiac pacing using any Guidant/Boston Scientific Implantable ICD or CRT-D System and any Guidant/Boston Scientific Intracardiac Lead System; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Myocardial Infarction
Interventions: Clopidogrel; Drug
Lead sponsor: North Texas Veterans Healthcare System; Federal
Eligibility: 21 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Hypogonadism, Acute Myocardial Infarction: Rehabilitation Phase
Interventions: Testosterone, Normal Saline; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years and older · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Odessa, Texas

Conditions: Heart Failure, Myocardial Infarction
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,599 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Myocardial Infarction, Angina, Unstable, Cardiomyopathy, Hypertrophic
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Acute Myocardial Infarction
Interventions: Post conditioning, Usual Care for STEMI; Procedure
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Acute Coronary Syndrome, Myocardial Infarction, Smoking
Interventions: Bupropion HCl ER, Placebo; Drug
Lead sponsor: Mark Eisenberg; Other
Eligibility: 18 Years and older
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 13
States / cities: Pueblo, Colorado • Lewiston, Maine • Bay City, Michigan + 9 more

Conditions: Myocardial Infarction
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years and older
Enrollment: 7,057 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 22
States / cities: Little Rock, Arkansas • Long Beach, California • Los Angeles, California + 19 more

Conditions: Myocardial Infarction, Heart Failure, Left Ventricular Remodeling
Interventions: VentriGel; Biological
Lead sponsor: Ventrix, Inc.; Industry
Eligibility: 30 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 6
States / cities: Gilbert, Arizona • Los Angeles, California • Gainesville, Florida + 3 more

Conditions: Percutaneous Coronary Intervention
Interventions: Wellframe; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 21 Years to 85 Years
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Respiratory Failure, Respiratory Arrest, Respiratory Distress Syndrome, Acute Respiratory Failure, Acute Respiratory Failure With Hypoxia, Acute Respiratory Failure With Hypercapnia, Acute Respiratory Failure Post Surgical, Acute Respiratory Failure Postprocedural, Acute Respiratory Failure Following Trauma and Surgery, Acute Respiratory Failure Requiring Reintubation, Acute Respiratory Failure Post Traumatic, Acute Respiratory Decompensation, Shock, Shock, Septic, Shock, Cardiogenic, Acute Cardiac Failure, Multi Organ Failure, Acute Kidney Failure
Interventions: Observational retrospective cohort to describe data validity; and Data reliability; and Completeness of the data; Other
Lead sponsor: Efficacy Care R&D Ltd; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 50,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Rohan Dharmakumar; Other
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Myocardial Inflammation, Myocardial Infarction
Interventions: Change in Soluble MER Concentration; Other
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: Up to 19 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Myocardial Infarction
Interventions: Aliskiren, placebo; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years and older
Enrollment: 820 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Novartis US, New Jersey

Conditions: Coronary Heart Disease, Myocardial Infarction
Interventions: Titration of medications, Lifestyle Counseling, Medication Counseling, Usual Care with Medication Reconciliation; Other · Behavioral
Lead sponsor: Middle Tennessee Research Institute; Other
Eligibility: 60 Years to 90 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Myocardial Infarction
Interventions: Dapansutrile, Placebo; Drug · Other
Lead sponsor: University of Virginia; Other
Eligibility: 25 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Myocardial Infarction, Death, Sudden, Cardiac
Interventions: Omega-3 Fatty Acids (Fish Oil Supplements), Placebo; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery, Genetic Predisposition to Disease, Atrial Fibrillation, Myocardial Infarction, Heart Failure
Interventions: Not listed
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 20 Years to 90 Years
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2030
U.S. locations: 3
States / cities: Boston, Massachusetts • Dallas, Texas • Houston, Texas

Conditions: Acute ST Segment Elevation Myocardial Infarction
Interventions: Not listed
Lead sponsor: Cardiovascular Research Foundation, New York; Other
Eligibility: 18 Years and older
Enrollment: 403 participants
Timeline: 2023 – 2024
U.S. locations: 8
States / cities: Miami, Florida • Naples, Florida • Dearborn, Michigan + 5 more

Conditions: Type 2 Myocardial Infarction
Interventions: Clinician-level intervention, Patient-level intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Myocardial Infarction
Interventions: Nesiritide, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 2
States / cities: Jacksonvilee, Florida • Rochester, Minnesota

Search by objective public record fields.

Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness

Readiness for Behavior Change After a Heart Attack

The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study

Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)

Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction

Ventricular Remodeling and Heart Failure After Myocardial Infarction: A Community Study

Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures

Minimizing Reperfusion Injury in Patients With Acute Myocardial Infarction

Measurement of Matrix Metalloproteinase Activation Post Myocardial Infarction

Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial

The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)

A Study of VentriGel in Post-MI Patients

A Smartphone-based Application Post-myocardial Infarction to Manage Cardiovascular Disease Risk

Postoperative Respiratory Abnormalities

Arrhythmias in Hemorrhagic Myocardial Infarction During the Acute Post-PCI Phase

Mer-TK in Human Cardiac Cells

Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE)

Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease

Multimodality Cardiovascular Imaging for the Translation of Therapies for Vascular Activation After MI

Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility

Enhancing Cardiac Rehabilitation Attendance After Secondary Myocardial Infarction Through Clinician Messaging and Motivational Calls

Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction